Most peer groups say they do not want to get involved with the politics surrounding RU-486, but will make students aware of the option, now that the drug has been approved by the FDA.

"We support anything that UHS does to make the aftermath of sexual assault easier for survivors. This includes easier or more available abortions," says Jennifer K. Price '02, co-chair of the Coalition Against Sexual Violence.

But PCC has been public in their support.

"Women should have as many contraception options as are possible, and just as many options for when that contraception fails," Tessier says. "This is just another way to increase options."

Though the new drug frees most women opting to have a RU-486 abortion from having to undergo a surgical procedure, Melissa R. Moschella '02, president of Harvard Right to Life, a pro-life student group, says that her organization still opposes the drug because it is used for abortions.

Moschella, who also wrote an editorial in Tuesday's Crimson criticizing the lack of resources available for pregnant women at Harvard, says she worries about the logistics of a RU-486 abortion.

"After taking the drug a student will naturally miscarry at any time and a college dorm or campus is not a suitable place for this to happen," she said Tuesday. "It has the potential to be more disruptive if widely used than to just the person involved."